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Pulmonary melioidosis, a disease manifestation caused by the bacterium Burkholderia
pseudomallei, has been studied using aerosols or intranasal (IN) inoculation in small
animal models. Both have inherent disadvantages which may not accurately model primary
pulmonary melioidosis in humans. Intratracheal inoculation (IT) by direct visualization
of the tracheal opening offers an alternative technique for infection that overcomes
the disadvantages of aerosol and IN challenge. In this study, we describe a method
which requires relatively inexpensive equipment, little training, and is compliant with
the operational constraints of a BSL3 laboratory. Results obtained using trypan blue
demonstrated that an inoculum can be accurately delivered into the lungs of mice within
a biosafety cabinet (BSC). Whole body imaging and histopathology confirmed that mice
inoculated intratracheally with B. pseudomallei develop the primary focus of infection in
the lungs, and not the nasal passages which can lead to invasion of the central nervous
system and potential neurologic complications. Further, based on colony counts and
bioluminescent imaging, dissemination to secondary organs occurred as expected. Taken
together, this intratracheal method of inoculation fulfills four goals: (1) to accurately deliver
B. pseudomallei into the lungs of the animal model, (2) to avoid potentially confounding
complications due to primary infections at sites other than the lung, (3) to maintain normal
organ dissemination, and (4) to be BSL3 compliant.
Keywords: pulmonary melioidosis, melioidosis, non-invasive inoculation method, intratracheal inoculation,
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INTRODUCTION
The bacterium Burkholderia pseudomallei is a gram-negative bac-
terial pathogen that is the etiologic agent of the disease melioido-
sis. Melioidosis is a serious and often fatal disease of humans and
animals which is endemic in Southeast Asia, northern Australia,
and other tropical areas of the world (Cheng and Currie, 2005).
Infection usually follows percutaneous inoculation or inhalation
of the bacterium that are present in soil and surface water. The
disease may be localized or disseminated, and virtually any organ
system can be affected, resulting in a wide range of symptoms
that are often mistaken for other illnesses, such as tuberculo-
sis or pneumonia (Loveleena et al., 2004). The overall mortality
rate of melioidosis in endemic areas may reach as high as 50%
(White, 2003).
While community-acquired cases of melioidosis are most
likely a consequence of the bacterium in soil or water entering the
host through cuts or skin abrasions, the bacterium is much more
infective via the inhalation route as determined in small animal
models of disease (Titball et al., 2008). This is possibly consistent
with the higher incidence of melioidosis during monsoon season,
when surface waters are aerosolized by severe weather, and the
higher incidence of reported cases in healthy American helicopter
crews during the Vietnam War, as a consequence of the inhala-
tion of dusts containing bacteria (Howe et al., 1971; Cheng and
Currie, 2005). The potential for the bacterium to cause disease
after inhalation, in addition to the high mortality associated with
the disease and the intrinsic antibiotic resistance, has resulted
in the inclusion of this pathogen on the list of potential bio-
logical warfare and bioterrorism agents, and the classification of
B. pseudomallei as a Tier 1 Select Agent by the Centers for Disease
Control (CDC) (Rotz et al., 2002). Since the anthrax attacks of
2001, the inhalation route has been given special interest because
it is a likely route to be exploited by bioterrorists.
Pulmonary melioidosis, caused by either inhalation or
hematogenesis spread, is an important sequela of the disease and
is present in over 50% of diagnosed cases (Cheng and Currie,
2005; Currie et al., 2010). It presents as a febrile condition which
includes coughing, respiratory distress, and production of spu-
tum (Vietri and Deshazer, 2007). Pulmonary melioidosis, caused
by inhalation, is a particularly pertinent area of study in the
disease process as the lungs represent the potential point of inoc-
ulation and dissemination into the body during a bioterrorist
attack.
The most commonly used animal models in the study of
melioidosis are the hamster and the mouse (Warawa, 2010). The
mouse is the most attractive model given its ease of use and
the tools available for studying genetics and physiology Both the
acute and the chronic forms of the disease can be studied in
mice using different genetic backgrounds, BALB/c and C57BL/6,
respectively (Leakey et al., 1998). Generally, pulmonary melioido-
sis has been studied using either aerosolization or intranasal (IN)
inoculation as the route of infection (Owen et al., 2009; Warawa,
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2010; Thomas et al., 2012). Both methods have advantages and
disadvantages for animal research. The aerosolization method
most closely resembles the route of natural infection in humans,
but depending on particle size and the anatomical parameters of
the animal, the procedure requires a higher titer of bacteria to
achieve study dosages within the lungs (Brain et al., 1976; Munder
et al., 2002). In the case of IN inoculation, the inoculum is applied
to the nares of the mouse and is respired through the nasal pas-
sage into the lungs, but the majority of the inoculum remains
within the nasal passages or is removed through the gastroin-
testinal tract; therefore, only a small portion of the inoculum is
translocated into the lungs (Watson et al., 1969; Su et al., 2004).
In addition, these routes of infection often result in high rates
of infections of the nasal-associated lymphoid tissue (NALT) and
olfactory tissues (CNS) in mice where such infections are uncom-
mon in humans (Currie et al., 2000; Owen et al., 2009; Warawa
et al., 2011). Consequently, these two methods may not accurately
model inhalational melioidosis in humans.
Intratracheal inoculation (IT) offers another potential route
of infection to study pulmonary melioidosis that avoids the
potential CNS infection associated with aerosolization and IN
inoculation by placing the inoculum directly into the trachea,
thereby bypassing the mouse nasal passages. IT inoculation has
the advantages of being able to introduce a known quantity of
sample directly into the lungs of the subject unlike either IN
inoculation or aerosolization (Watson et al., 1969; Driscoll et al.,
2000). Both surgical and non-invasive methods have been used to
introduce various substances and bacteria directly into the lungs
of mice to study toxicity or virulence (Ho and Furst, 1973; Brain
et al., 1976; Lawrence et al., 1977; Starcher and Williams, 1989;
Hastings and Summers-Torres, 1999; Driscoll et al., 2000; Munder
et al., 2002; Su et al., 2004; Guilbault et al., 2005; Lacher et al.,
2010). Non-invasivemethods of IT inoculation present less risk to
the investigator, require less training, require less time for the pro-
cedure, and have less specialized equipment than aerosol delivery
systems. The above points are especially important for studies
with B. pseudomallei which necessitate the use of a biosafety
cabinet (BSC) within a biosafety level 3 (BSL3) laboratory.
The purpose of this study was to develop a non-invasive
intratracheal delivery method that fulfilled four main goals: (1)
accurate delivery of the inoculum into the lungs of the animal,
(2) models the pulmonary route of infection avoiding poten-
tial confounding complications due to neurologic melioidosis,
(3) maintain organ dissemination as seen during the typical
B. pseudomallei infection, and (4) is BSL3 compliant.
MATERIALS AND METHODS
BACTERIAL STRAINS AND GROWTH
B. pseudomallei DD503 containing the luxCDABE (JW280)
operon from Photorhabdus luminescens (Warawa et al., 2011),
was grown in Luria broth-Lennox (Difco) supplemented with
4% glycerol (LB4G) at 37◦C with shaking for all experiments.
Brucella agar (Difco), supplemented with 4% glycerol (B4G),
was used to recover bacteria from organs. Modified Ashdown’s
agar (Ashdown, 1979) containing polymyxin B (100µg/ml) was
used to recover bacteria from the lungs. All experiments con-
ducted with B. pseudomallei were performed in a BSL3 laboratory
using Select Agent compliant BSL-3/ABSL-3 containment and
procedures.
EXPERIMENTAL ANIMALS
For trypan blue staining of the lungs, mice bred at Rocky
Mountain Laboratories, NIAID/NIH, designated RML were
used. For infections and imaging using B. pseudomallei, female,
BALB/c, 8- to 10-week-old mice were obtained from Charles
River Laboratories (Wilmington, MA). In preparation for imag-
ing and before inoculation, mice were anesthetized using 3–4%
isoflurane, and the fur removed on their dorsal thoracic cavi-
ties by shaving to reduce interference during imaging. All studies
were performed in accordance with the Institutional Animal Care
andUse Committee’s guidelines at RockyMountain Laboratories,
NIH, Hamilton, MT.
EQUIPMENT
Backboard
Plexiglass (6mm thick) was cut to measure approximately 42 cm
in length by approximately 22 cm in width and bent to a 45◦ acute
angle. Two holes were drilled on each side of the backboard 2 cm
from the top and side edge. Galvanized metal-style screws, nuts,
and washers were used to secure a stainless steel wire strung from
one screw to the other from which a mouse could be hung by its
incisors (Figure 1A). For surface decontamination, 2% Roccal-D
(Pfizer Inc, New York) was regularly used as 70% ethanol caused
cracking and eventual breakage of the backboard.
Gastight syringe and needle
Fifty microliter gastight syringes with removable needles (model
1705 RN SYR) were obtained from the Hamilton Company
(Reno, NV). Gastight syringes were used in conjunction with
FIGURE 1 | Equipment. (A) Backboard constructed of plexiglass with wire
strung between screws. (B) Gastight syringe (50µl total volume) with bent
and blunted 22s gauge needle. (C) General equipment arrangement within
a biosafety cabinet. (D) Instillation procedure with lightsource placement,
withdrawn tongue, and placement of the gastight syringe.
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custom 22s gauge, small hub, blunt, and needles approximately
25mm in length. Needles were bent in order to facilitate direct
instillation of bacteria into the trachea (Figure 1B).
Surgical loupes
Dental/medical loupes (6X, 550mm working distance) were used
to directly visualize the larynx and tracheal opening through the
glass sash of the BSC during instillation.
INTRATRACHEAL INOCULATION
Mice were anesthetized using an isoflurane vaporizer and induc-
tion chamber (Matrx VIP3000, Midmark, Orchard Park, NY).
After animals became recumbent, mice were injected intraperi-
toneally (IP) with 80µl of a cocktail of ketamine (25mg/ml) and
xylazine (1.2mg/ml) and returned to the isoflurane induction
chamber. For inoculation, animals were removed from the cham-
ber and suspended on the plexiglass backboard in the supine posi-
tion by their incisors (Figure 1D). A lightsource (Dolan-Jenner
Model MI-150 Illuminator, VWR International, Bridgeport, NJ)
was used to illuminate the tracheal opening by positioning a
fiber optic arm over the front side of the throat (Figure 1D). The
mouth was opened and forceps were used to extend the tongue
out of the mouth and to the side and the needle was used to
gently reposition the soft palate to expose the tracheal opening
(Figure 1D). The needle was inserted between the vocal cords
(Figure 2) to inoculate.
To determine lobular involvement, intrapulmonary staining
was achieved by the introduction of 20µl of 0.4% trypan blue
(Gibco) using the procedure described above. RML mice were
euthanized and lungs excised. The effectiveness of the technique
was determined empirically by observing the number of lobes
exhibiting trypan blue staining.
FIGURE 2 | Mouse oropharynx anatomy. The mouse in the supine
position with the incisors (I) at the bottom and the tongue (T) located at the
top of the figure. The tracheal opening (TO), epiglottis (E), vocal chords (VC),
and soft palate (SP) are labeled.
BACTERIAL CHALLENGE AND BIOLUMINESCENT IMAGING
Bacteria were inoculated from overnight cultures into fresh LB4G
and incubated at 37◦C with shaking to an OD600 of 0.4. Animals
(n = 3 − 4) were inoculated with 1 × 104 CFUs of B. pseudo-
mallei JW280 in a total volume of 20µl for IT inoculation,
or 30µl in the left nare for IN inoculation. At time 0, 24,
48, and 72 h post-infection, mice were imaged with an IVIS
Lumina imaging system (Caliper Lifesciences, Hopkinton, MA)
using a Xenogen animal isolation chamber (Caliper Lifesciences,
Hopkinton, MA) for biocontainment during the imaging
procedure.
For imaging, mice were placed inside the animal isolation
chamber within a BSL3-compliant BSC. The isolation chamber
was surface decontaminated, removed to the IVIS imaging cham-
ber and connected to the in-chamber anesthesia delivery system
(Xenogen XGI-8 Gas Anesthesia System, Caliper Lifesciences,
Hopkinton, MA). Isoflurane was applied to the chamber until
the mice became recumbent. The isolation chamber was then
placed into the imaging chamber and reconnected to the anesthe-
sia delivery system. Bioluminescence was measured using 5min
exposures.
All mice were euthanized and dissected immediately at 72 h
post-infection. Ex vivo images of the lungs, liver, and spleen were
obtained by containing organs in a petri dish in the isolation
chamber. The isolation chamber was positioned in the imaging
cabinet and organs were imaged using 5min exposures.
Bioluminescence was quantitated using total radiance of the
dorsal thoracic and nasal regions of infected animals using Living
Image software 3.0 (Caliper Lifesciences). The units of aver-
age radiance are photons/second/square centimeter/solid angle
(p/s/cm2/sr). Graphing and statistical analysis was performed
using an unpaired t-test analysis in GraphPad Prism 5 (GraphPad
Software Inc.).
BACTERIAL ENUMERATION
Organs were homogenized using a Mini-Beadbeater-1 (BioSpec
Products, Inc., Bartlesville, OK) and Lyzing Matrix H (MP
Biomedicals, Solon, OH). Lyzing Matrix H tubes containing
2mm glass and 2mm yellow zirconium oxide beads were used to
homogenize tissue samples. The tubes were filled with 0.5ml of
1X PBS (Gibco) and preweighed before entering the BSL3. After
dissection, organs were placed into tubes and weighed. Organs
were homogenized on high setting for 10 s serial diluted, and
plated onto B4G or Modified Ashdown’s Media (lungs). All steps
involving the bacterium were performed in a BSC.
HISTOLOGIC ANALYSIS
Animals were euthanized and tissues were harvested for
histopathologic analysis. At dissection, lungs were inflated with
10% formalin and then immersed in formalin for a mini-
mum of 48 h. Tissues were fixed in formalin, processed, and
stained with hematoxylin and eosin. Mouse heads, as part of
processing, were decalcified using EDTA in 20% sucrose and
sectioned. Histopathology of the nasal nares, brain, lung, liver,
and spleen were scored as previously described (Warawa et al.,
2009). Statistical analysis was performed using GraphPad Prism 5
(GraphPad Software Inc.).
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RESULTS
TARGETING THE LUNG
As a first step to evaluating the use of IT inoculation for mouse
infections, we wanted to ensure the accurate targeting of the lung
within the confines of BSL3 operating procedures. To do this, 10
mice were inoculated with trypan blue stain. In order to achieve
inoculation directly into the lungs, dental/surgical loupes (work-
ing distance 55 cm) are used to visualize and differentiate the
anatomy of the larynx of the mice. The depth of field (ca. 10mm)
of the dental/surgical loupes allows the visualization of the mouse
larynx and insertion of the needle into the tracheal opening. As
Figure 2 demonstrates, when the lightsource is positioned over
the front of the throat, the tracheal opening and the vocal chords
are easily differentiated from other anatomical structures. The
soft palate was repositioned using the syringe by gently depress-
ing downward toward the dorsal side of the mouse, exposing the
tracheal opening.
It should be noted that different anesthetics alter the con-
figuration of murine oropharyngeal anatomy. The tracheal
opening remained occluded and difficult to identify when the
ketamine/xylazine cocktail was used as the sole anesthetic. When
isoflurane was used as the sole anesthetic, the tracheal open-
ing remained unobscured and easily identifiable. However, use
of isoflurane as the sole anesthetic was judged to be problematic
due to the requirement of a continuous delivery because of the
short-lived effects of the anesthesia. This could allow the animal
to become active during inoculation and the use of a continuous
delivery system could obstruct the view of the oropharynx. To
mitigate unnecessary risk and abolish maintenance of the swal-
lowing reflex, the ketamine/xylazine cocktail was used in addition
to isoflurane. Animals were injected with the ketamine/xylazine
cocktail, allowed to become recumbent, and immediately prior
to performing the procedure in the BSC were induced with 2.5%
isoflurane to abolish the swallowing reflex. The result of the try-
pan blue stain inoculation is shown in Figure 3. Trypan blue was
observed in the lungs of all 10 mice. Importantly, inoculation by
FIGURE 3 | Intratracheal delivery of trypan blue.Mice were anesthetized
with 2.5% isoflurane and instilled with 20µl of a 0.4% trypan blue solution.
Mice were euthanized and the lungs harvested. Left lobe (LL) is labeled for
orientation.
this method will allow for the delivery of an agent into multiple
lobes of the lungs (Figure 3).
BIOLUMINESCENT IMAGING OF INTRATRACHEAL AND INTRANASAL
INOCULATIONS
The common practice of mouse IN inoculations typically results
in infections of the nasal cavity and invasion of the CNS not nor-
mally seen in humans. To demonstrate the effectiveness of IT
inoculations to specifically target the lungs without CNS involve-
ment, mice were challenged with a bioluminescent strain of
B. pseudomallei, JW280, and imaged over 3 days. For compari-
son, the mice were also inoculated using IN inoculation method.
The relative bioluminescent intensity is indicative of the bacterial
cell density, therefore, the relative light intensity can be used as a
measure of bacterial infection. At times 0, 24, and 48 h, no sig-
nificant luminescence was observed in mice from either challenge
(data not shown). At 72 h, significant luminescence was observed
in both IT and IN inoculated mice. In IT inoculated mice, bio-
luminescence was observed emanating mainly from the thoracic
region of the mouse with little or no luminescence observed
from the nasal cavity region (Figure 4A, panel IT). In contrast,
mice inoculated by the IN inoculation method showed significant
amounts of luminescence in the nasal region and relatively lit-
tle luminescence from the thoracic region (Figure 4A, panel IN).
The difference in luminescence between the two procedures was
quantified by calculating the average radiance for the thoracic and
nasal regions of each mouse. The results are shown in Figure 4B.
In mice infected by IT inoculation, the thoracic regions exhibited
no significant increase in average radiance (11,373 p/s/cm2/sr)
compared to the average radiance in mice infected by IN inocula-
tion (6970 p/s/cm2/sr; p = 0.2849), indicating that IT inoculation
results in infectivity of the lung at the same level as the commonly
used IN inoculation procedure. Importantly, in mice infected
by IN inoculation, the nasal regions exhibited approximately
5-fold higher average radiance (33,767 p/s/cm2/sr) compared to
the average radiance in mice infected by IT inoculation (6,760
p/s/cm2/sr) demonstrating a marked decrease in nasal infections
when the mice are inoculated IT.
To further characterize the nasal infections and determine
CNS infiltration, histopathology of the nasal cavity and the brain
was assessed using tissues collected 72 h post-inoculation. The
results are shown in Figure 5. In mice infected by IN inocula-
tion, inflammatory cell infiltrates and hemorrhaging are present
in the olfactory bulbs (CNS) and in the olfactory nerve filaments
descending from the CNS through the cribriform plate into the
nasal epithelium. Additionally, necrotic lesions present through-
out the nasal epithelium (necrotizing rhinitis) and inflammatory
exudate in sinus cavities indicate significant nasal infection and
CNS infiltration (Figure 5A). In contrast, olfactory bulbs from IT
infected mice exhibited no inflammation or hemorrhaging, nor-
mal nasal epithelium and no evidence of inflammatory exudate
(Figure 5B).
The difference in luminescence was also determined in the
organs of animals infected IT vs. IN inoculation. Mice were
euthanized after whole-body imaging at 72 h, and the lungs,
liver, and spleen were immediately harvested and imaged. The
results are shown in Figure 4C. Luminescence was quantitated
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FIGURE 4 | In vivo and ex vivo imaging of B. pseudomallei infections
comparing IT and IN inoculation methods. Mice were infected with 104
cfu of B. pseudomallei JW280. (A) Mice were inoculated by either IT or IN
inoculation methods and imaged using an IVIS Lumina system at 72h.
(C) At 72h, mice were euthanized and organs were harvested and imaged.
(B and D) Light emission using average radiance (photons/second/square
centimeter/steradian) from (B) whole-body and (D) harvested organs as
determined using Living Image 3.0 software. All images were normalized to
the same average radiance scale. (E) Bacterial burden determination in
homogenized organs. *p = 0.0279.
using the Living Image software (Caliper Lifesciences). In each
case there was no significant difference in luminescence of the
organs between inoculation by IT and IN (Figure 4D). To cor-
relate light intensity to bacterial burden in the organs, the
organs were homogenized, serial diluted, plated, and colonies
counted. No significant difference in bacterial burden between
methods (Figure 4E) was found for the lungs (unpaired t-test,
p = 0.3767), the liver (unpaired t-test, p = 0.6906), the spleen
(unpaired t-test, p = 0.3173), and the blood (unpaired t-test,
p = 0.3405). Taken together, these results demonstrate that this
method directly and accurately targets the lungs and results in a
pulmonary infection at the same or higher levels than that of the
more commonly used IN inoculation procedure. Furthermore,
inoculation by IT does not result in primary CNS infection.
CONCLUSIONS
The potential for outbreaks of melioidosis following a bioter-
rorist attack has led to increased interest in understanding asso-
ciated virulence factors and disease course produced by the
bacterium B. pseudomallei. Studies have been performed using
several methods of inoculation to mimic different routes of infec-
tion such as subcutaneous and intraperitoneal (percutaneous),
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FIGURE 5 | Histopathology of IN infected mice demonstrated damage
of the CNS and nasal epithelium. Nasal and olfactory tissue from mice
infected by IT or IN inoculation with 104 cfu of B. pseudomallei JW280. The
heads of (A) IN-infected or (B) IT-infected mice were harvested at 72h,
fixed with formalin, embedded, and stained with hematoxylin and eosin.
Histological sections were imaged by bright field microscopy.
oral (ingestion), and IN and aerosol (inhalation) (Jeddeloh et al.,
2003; Barnes and Ketheesan, 2005; Tan et al., 2008; Lever et al.,
2009; Owen et al., 2009). Among these, inhalation is the most
probable route for bioterrorist delivery of B. pseudomallei, which
most likely would result in infections of the lung, i.e., pulmonary
melioidosis. The most common inoculation methods utilized to
mimic the airborne route are IN and aerosol. While both methods
result in infections of the lung and exhibit normal organ dissemi-
nation, neurological abnormalities appear to be overrepresented,
possibly due to the anatomical differences of the upper respiratory
tract (URT) between mice and humans.
Rodents, unlike humans, are obligatory nose-breathers, and
divergent evolution has equipped the animal with a URT devel-
oped for enhanced olfactory senses (Reznik, 1990). Thus, rodents
have a greater relative surface area in the URT than humans pos-
sess (Warawa, 2010). Along with the greater surface area and
enhanced olfaction, specific tissue types are likely to be over-
represented in the mouse compared to the human, such as
olfactory-associated epithelium. The combination of a larger rel-
ative surface area with comparatively overrepresented tissues in
the URT of rodents may complicate the study of B. pseudomallei
infections by overrepresenting specific portals of entry depend-
ing on the route of inoculation. Any route of inoculation that
depends on the normal inspiratory route of the rodent, such as
IN or aerosol, could potentially favor these alternative portals of
entry to the body. In addition, IN inoculation results in only a
fraction of the bacteria reaching the lungs leaving a major pro-
portion to localize in the URT (Munder et al., 2002; Su et al.,
2004). Olfactory epithelium and the trigeminal nerve may serve
as portals of entry to the CNS and, as such, IN inoculation has
been utilized to study B. pseudomallei CNS infection (Owen et al.,
2009). Neurologic abnormalities present during infection with
B. pseudomallei, with or without evidence of direct invasion of
the CNS, has been termed neurologic melioidosis and is con-
sidered “unusual” in humans, occurring in approximately 3–4%
of all melioidosis cases (Currie et al., 2000, 2010; Koszyca et al.,
2004; Owen et al., 2009). Because of this low incidence level, an
animal model which frequently results in neurologic melioido-
sis may not accurately model inhalation melioidosis in humans.
In fact, in humans, pulmonary melioidosis is the more common
manifestation of disease resulting from inhalation of bacteria,
with around half of all melioidosis patients presenting with pneu-
monia (Currie, 2003). Thus, a more accurate animalmodel would
be one that specifically targets the lower respiratory tract resulting
in pulmonary melioidosis in the mouse.
Intratracheal instillations have been used to deliver test mate-
rials directly into the lungs of mice in numerous studies (Ho
and Furst, 1973; Brain et al., 1976; Lawrence et al., 1977; Lacher
et al., 2010), but is not widely used to model mouse pulmonary
melioidosis. Many of these reports detail methods of both inva-
sive and non-invasive procedures of intratracheal instillation.
However, to our knowledge there is no report in the literature of
a method specifically suited for BSL3 compliance. The method
detailed in this report fulfills four important goals of this study
which are: (1) accurate delivery of the inoculum into the lungs
of the animal, (2) models pulmonary route of infection avoiding
potential confounding complications due to neurologic melioi-
dosis, (3) maintains organ dissemination as seen during typical
B. pseudomallei infection, and (4) is BSL3 compliant.
Since our lab primarily focuses on pulmonary melioidosis, IT
inoculation was chosen as the method of infection in order to
deliver a known number of bacteria directly to the lungs and
thereby bypass the URT of the mouse. In initial experiments,
the inoculations were performed as previously reported using the
“blind” or “feel” approach. In this technique the inoculum is
introduced by following the midline of the tongue to the back
of the pharynx over the epiglottis and into the tracheal open-
ing, not through visualization of the tracheal opening. Using this
technique, we observed a low accuracy of instillation into the
lungs of between 10 and 20%. The inoculum was generally found
in the esophagus or in the extratracheal tissue due to perfora-
tion of the trachea. Based on these results, we determined that
a direct visualization approach to introduce a sample would be
more advantageous.
Most methods for non-invasive intratracheal inoculation
require some basic equipment: (1) an apparatus to magnify the
larynx for visualization of the tracheal opening, (2) a lightsource
to illuminate the oropharynx, and (3) a device to deliver the
inoculum. In addition, working with B. pseudomallei requires the
user to perform all tasks within the confines of the BSC within
a BSL3 laboratory. To best meet these requirements, our proce-
dure utilizes an angled plexiglass backboard optimized for use in a
BSC, dental/surgical loupes, a small-volume syringe with a mod-
ified needle, and a lightsource. In our experience, dental loupes
are the best option to visualize the anatomy and precisely target
the lungs because focus may be adjusted simply by head move-
ment freeing the operator’s hands from extraneous movements
that might disrupt airflow in the BSC (Figure 1C). In addition,
because the operator can see the needle entering the trachea,
the actual inoculation procedure can be performed in under a
minute. Using this method multiple lobes of the lung are involved
(Figure 3). Although this may not exactly replicate inhalation,
IT inoculation has been shown to reach deeper lung tissue than
aerosol challenge and to deliver a known quantity of bacteria
(Watson et al., 1969; Driscoll et al., 2000; Munder et al., 2002).
It should be noted that this method assumes the use of an N95 or
similar respirator and is not amenable for use with a PAPR.
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Based on whole-body luminescent imaging, inoculation by
IN and IT differed in the pattern of infection with respect to
where the focus of infection was observed. Mice infected by IN
inoculation appeared to have a primary focus of infection in the
region of the nasal cavity at 72 h post-infection whereas the pri-
mary focus of infection at the same time for mice infected by
IT inoculation was in the area of the thoracic cavity (Figure 4).
This characteristic differential focus of infection can only be
attributable to the method of inoculation since the same inocu-
lum was given to both groups, and is supported by other studies
which demonstrate a focus of infection in the nasal passages after
IN inoculation (Owen et al., 2009; Massey et al., 2011; Warawa
et al., 2011). Using histopathology, we observed significant hem-
orrhaging and necrosis at 72 h post-infection by IN inoculation
with B. pseudomallei in the nasal epithelium and the olfactory
bulbs, confirming the results of previous studies (Figure 5). This
also indicated that inoculation by the IN route may overrepresent
neurologic melioidosis in murine animal models, an uncom-
mon presentation in humans. IT inoculation offers an alternative
method of inoculation which bypasses nasal-associated routes of
entry and focuses on the early infection in the lungs. In con-
trast to mice infected by IN inoculation, histopathology of the
nasal passages and CNS of IT infected mice suggest the lack of
involvement of those tissues during challenge with B. pseudo-
mallei during early infection, since no inflammation or hemor-
rhaging was observed after IT inoculation (Figure 5). This offers
the investigator the advantage of studying pulmonary melioidosis
without potentially confounding neurological involvement, such
as spread of bacteria through the NALT or CNS to other sites in
the body.
There does appear to be a disparity between the amount of
observed luminescence and bacterial burden of the lungs. We
attribute this to differential deposition in the lungs due to the dif-
ference in methods. It has been demonstrated that infection by
IT inoculation results in a localization of the inoculum deeper
into the lung which resulted in bacteria being deposited in the
portion of the lung closest to the skin (Watson et al., 1969). In
mice inoculated by IN, the bacteria are deposited more shallowly
(Watson et al., 1969). The depth and density of the tissue to be
imaged within the body presents a major barrier to the detec-
tion of emitted light. Light emitted from deeper tissues is hard
to detect because of the intervening tissues blocking the light.
The difference in deposition of the bacteria between the methods
would account for the difference in the observed luminescence.
To accurately study the progression of disease, it is impor-
tant that the route of infection allows for the dissemination of
the bacteria to secondary organs. Although the lungs may be the
primary focus of infection, virtually any organ system can be
affected, including the liver and spleen (White, 2003; Currie et al.,
2010). Previous studies have demonstrated “normal” bacterial
dissemination when animals were infected by the IN inoculation
method, indicating that the lungs, liver, and spleen of animals
were infected (Warawa et al., 2011). In this paper, we demon-
strated that there is no significant difference between the IN
and IT inoculation methods for bacterial burden in the lungs,
liver, spleen, or blood. This suggested that dissemination using
either method resulted in equivalent spread to those organs after
72 h (Figure 4). Taken together, these results indicated that the
IT inoculation method of infection was a powerful tool in the
study of pulmonary melioidosis. In addition, because this proce-
dure requires minimal training and readily-available, inexpensive
equipment, this method should be easily adaptable to the study of
pulmonary infections for other select agents.
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